## Max Healthcare Institute Limited (MAXHEALTH) Stock Analysis

This report analyzes Max Healthcare Institute Limited (MAXHEALTH) stock based on the provided data.  The analysis focuses solely on the provided data and does not consider external market factors or sentiment.

**1. Data Preprocessing:**

The provided data has been parsed and organized into the following sections:

**1.1 Company Profile:**

| Feature          | Value                               |
|-----------------|---------------------------------------|
| Symbol           | MAXHEALTH                           |
| Company Name     | Max Healthcare Institute Limited      |
| Industry         | Hospital                             |
| ISIN             | INE027H01010                         |
| Listing Date     | 2020-08-21                           |


**1.2 Market Data:**

| Metric                | Value      |
|-----------------------|-------------|
| Last Price            | 1163.05     |
| Change                | -17.65      |
| % Change              | -1.49%      |
| Previous Close        | 1180.7      |
| Open                  | 1180.7      |
| Close                 | 1165.2      |
| VWAP                  | 1176.66     |
| Week High             | 1215.55     |
| Week Low              | 630.9       |
| Sector PE             | 108.39      |
| Symbol PE             | 108.39      |
| Total Traded Volume   | 36.91       | (Note: This seems unusually low, potential data error)
| Delivery Quantity     | 2811660     |
| Delivery to Traded % | 76.18%      |
| CM Daily Volatility   | 2.27%       |
| CM Annual Volatility  | 43.37%      |


**1.3 Pre-Open Market Data:**

The pre-open market data shows a relatively stable pre-open price around the previous close, with higher buy orders than sell orders at lower prices.  However, the final pre-open price matched the previous close.

**1.4 Corporate Actions:**

| Ex-Date      | Purpose                     |
|--------------|------------------------------|
| 23-Aug-2024  | Dividend - Rs 1.5 Per Share |
| 08-Sep-2023  | Dividend - Re 1 Per Share    |


**1.5 Recent Announcements:**

Several announcements related to general updates and analyst/institutional investor meetings have been made in the last few months.  Specific details of these announcements are not provided.


**1.6 Financial Results (Last Five Quarters):**

| Quarter      | Income     | Expenditure | Profit After Tax | EPS     |
|--------------|------------|-------------|-----------------|---------|
| Q2 FY25      | 81,962     | 50,147      | 23,130           | 2.38    |
| Q1 FY25      | 66,426     | 46,110      | 15,414           | 1.59    |
| Q4 FY24      | 74,788     | 45,726      | 24,177           | 2.49    |
| Q3 FY24      | 63,343     | 43,010      | 15,812           | 1.63    |
| Q2 FY24      | 64,491     | 43,488      | 16,131           | 1.66    |


**(Note:  All financial figures are likely in thousands or millions of the local currency.  Units are not specified in the data.)**


**1.7 Shareholding Patterns:**

Promoter holding has slightly decreased from 23.76% to 23.74% over the last year.  Public holding has correspondingly increased.


**1.8 Board Meetings:**

Several board meetings have been held recently, primarily to discuss and approve financial results and dividends.


**1.9 Key Management Personnel:**

The provided data lists several directors and their designations, but detailed biographical information is absent.


**2. Key Indicators:**

**2.1 Current Price Analysis:**

* The current price (1163.05) is below the previous close (1180.7), indicating a downward trend.
* It's also below the week's high (1215.55) but above the week's low (630.9).
* Pre-open activity showed some buying interest but ultimately closed at the previous day's close.

**2.2 Financial Performance:**

* Revenue shows some fluctuation but generally an upward trend over the last five quarters.
* Profit after tax and EPS also show some fluctuation but generally an upward trend.

**2.3 Shareholding Analysis:**

* Promoter holding has slightly decreased, which might be a minor negative signal, but the change is not significant.

**2.4 Corporate Action Summary:**

* Two dividends have been declared recently, indicating a commitment to shareholder returns.

**2.5 Volatility and Risk:**

* Daily volatility (2.27%) is relatively low, suggesting lower short-term risk.
* Annual volatility (43.37%) is moderate, indicating moderate long-term risk.

**2.6 Key Directors and Contact Info:**

Contact information for the registrar and company is provided.  A list of directors and their designations is also available.


**3. Final Verdict:**

Based solely on the provided data, the recommendation is **Hold**.

**Reasoning:**

* While the recent price action shows a slight downward trend, the financial performance over the last five quarters shows a generally positive trend in revenue, profit, and EPS.
* The recent dividend announcements are positive.
* The relatively low daily volatility suggests lower short-term risk.
* The slight decrease in promoter holding is not significant enough to be a major concern.
* The unusually low total traded volume in the market data raises concerns about the accuracy of that specific data point.  Further investigation would be needed to verify this.

**Conclusion:**

Max Healthcare Institute Limited shows signs of reasonable financial health and a commitment to shareholder returns.  However, the current price is slightly down, and the low trading volume warrants further investigation.  A "Hold" recommendation is appropriate until more information is available to clarify the low trading volume and confirm the overall market trend.  Further analysis with more comprehensive data, including industry benchmarks and future projections, would be beneficial for a more informed decision.
